Kymanox News

Welcome to the News Headquarters for Kymanox. Releases are listed in chronological order, starting at the top with the most recent news. If you would like more information on a specific topic, please email info@kymanox.com or visit the Contact Us page.


24OCT17: Kymanox Exhibits at Georgia Bio Innovation for the First Timea5ccf536-a955-42c3-8445-d12b2a5981e9-original

As Kymanox expands across the US, remote team members take advantage of local events. The Georgia Bio Innovation Summit was held adjacent to our Alpharetta, GA hub. At this event, Georgia’s leadership in innovation, from basic research to manufacturing, to improve the health and well-being of people, animals, and the environment was showcased. Kymanox’s Client Services team shared our solutions with students, thought-leaders, and executives in the Life Science industry. The event also featured a Casino Night which helped aid in networking opportunities.

 


11-12SEP17: Kymanox Exhibits at the 2017 PDA/FDA Joint Regulatory Conference20170912_201225updated

For more than 25 years, the U.S. FDA and PDA have collaborated on the PDA/FDA Joint Regulatory conference. Participants have the opportunity to engage directly with FDA representatives and hear updates on current efforts affecting the development of global regulatory strategies. Industry experts present case studies illustrating how they use global strategies to improve the quality of medical products. This year’s theme was “Ensuring Product Quality in an Era of Innovative Therapies.” Kymanox team members attended and exhibited at both days of the conference, and connected with several industry executives.


8AUG17: Kymanox Hosts Inaugural CF Pig Pickin’ d486f3db-ba48-47bb-9f8a-f318022c771d-original.jpeg

Kymanox hosted its first ever Kymanox Cystic Fibrosis Pig Pickin’ on Friday 8AUG17. The invitation-only event was held at the Mystic Farm and Distillery in Durham, North Carolina and featured entertainment from The Gravy Boys as well as a spread of food from Backyard Bistro. During the event, attendees heard from Alan Youngblood, a friend of Kymanox who is living with Cystic Fibrosis. He shared his story and explained how medical advances have continued to impact and lengthen his life.


13JUL17: Kymanox Expanding, Hiring For Several New Positions

New Full-Time, Permanent Jobs Have Been Created at Kymanox

Research Triangle Park, North Carolina, United States  |  Thursday, 13 July 2017  |  Kymanox management has approved seven new positions to usher in next growth spurt.

Kymanox is working hard to help clients bring modern medicine to patients in need. To support both current and upcoming commercialization programs for new biologics, drugs, devices, and combination products, seven new positions have been defined and budgeted for immediate hiring.

“These latest openings reflect the growth trajectory of Kymanox and the demand for our type of services,” stated CEO and Founder Stephen M. Perry, “and we are grateful to have this opportunity to onboard additional talent to expand the capabilities of our existing, high-performing team.”  Six of the positions are located at Kymanox global headquarters in the Research Triangle Park (RTP) of North Carolina; the other position is located in the greater Atlanta, Georgia market.  The positions are a blend of both senior, mid-level, and entry-level in all four verticals at Kymanox: Quality + Compliance, Validation, Process Operations, and Project Management.

Kymanox has hired at a pace of greater than one person per month for the last year and plans to continue at that pace for the foreseeable future. As part of recent hiring, the management team at Kymanox gained two high-profile persons in Richard A. Motruk for Director of CGMP Manufacturing and Technical Operations and Ash Patel for Senior Director of Client Services. The company is looking for individuals that want to help the world produce modern medicine more quickly, more affordably, and with the highest quality and safety standards possible. With a reputation of providing unparalleled contract services, the existing team of process operations, quality assurance, regulatory compliance, validation, and project management experts provides an outstanding opportunity for learning and career advancement.

Click here for the Official Press Release

 To see the new available positions visit our Careers Page!


15JUN17:Kymanox leaders speak at PDA Southeast Chapter Spring Conference and Vendor Show

Stephen M. Perry, CEO, and Ash Patel, Senior Director of Client Services, joined the lineup of speakers discussing challenges faced by aging facilities. Members of the Client Services team also spoke to industry leaders about Kymanox’s solutions and made new connections while exhibiting.


17MAY17:Kymanox Celebrates Diversity at Triangle Curling Club

On a regular basis, Kymanox honors its diverse employee base by gathering together and celebrating one of its team member’s heritage. As there are two Canadians on the team, Triangle Curling Club was the chosen venue. Along with this challenging team-building activity, those in attendance got to enjoy a delectable Canadian dessert, butter tarts!


16MAY17:Kymanox partners with Shire at CPhI North American Conference b27e45cf-73e5-4dd9-8cd3-f8b95af8f2ff-original

The inaugural CPhI North American conference in Philadelphia, PA proved to be a great event for pharmaceutical industry professionals. Kymanox’s CEO Stephen M. Perry and Shire’s Head of Global Drug Product Manufacturing Science & Technology Stelios Tsinontides, PhD presented on Proven Practices to Speed Up Commercial Tech Transfers & Achieve RFT.


ash2

15MAR17:Kymanox Growth Continues, Signs Former Biogen Director

Ash Patel Joins Kymanox as New Senior Director of Client Services

RESEARCH TRIANGLE PARK, N.C., March 15, 2017 /PRNewswire/ — Mr. Patel joins Kymanox as an accomplished Operations Director with more than 20 years of experience in Supply Chain, Quality and Manufacturing Operations, Engineering, Capital Projects, Validation, and IT/Automation. He has General Management experience in multi-national biotech companies, such as Biogen and Diosynth Biotechnologies, with a strong record of compliance and value creation. Mr. Patel brings his highly developed communication and leadership skills to help Kymanox clients who are facing a variety of mission-critical challenges.  Also valuable is his international experience that encompassed expansion in Europe, Asia Pacific, and South America with successful implementation of relevant EU and US regulatory requirements.

Mr. Patel earned a degree in Electrical Engineering from the University of Sunderland in England, and is a Master of Business Administration (MBA) from Copenhagen Business School in Denmark. He maintains professional certifications in Quality Auditing (ASQ-CQA), Supply Chain (CSCP), and Quality Management / Organizational Excellence (ASQ-CMQ/OE).

Mr. Patel states, “I am very excited to be part of this family. The offerings we provide to Biotech, Pharmaceutical, Medical Device, and Sterile Pharmacy organizations is expansive and inclusive of many disciplines. We are providing world-class service unmatched in quality and net value. I look forward to building on the strong foundations and relationships already here.”

“Ash is a strategic addition to the Kymanox team,” CEO and Founder Stephen M. Perry remarked. “His new role ensures our continuing ability to understand the complex problems facing our clients who are bringing modern medicines to patients in need around the world.”


motruck1cropped

Richard Motruk joins Kymanox as new Director of CGMP Manufacturing

06MAR17: Kymanox Expands, Signs New Director of Manufacturing Operations

Richard Motruk has over 15 years of combined experience in the biopharmaceutical and medical device industries.  He earned a Bachelor of Science in Biochemistry and Molecular Biology from Penn State University.  He brings his proven expertise leading both technical and operations-focused teams, small and large, to Kymanox and their client base.

In regards to his new employment at Kymanox, Mr. Motruk expressed his excitement in being able to leverage his diverse Life Science experience to assist clients improve their operational efficiencies while maintaining or exceeding their quality and compliance levels.  “Kymanox is highly regarded for its expertise in many facets of CGMP manufacturing, chemistry, and related controls.  The idea of joining an industry leader, and being able to parlay my operational leadership experience gained at bioMérieux, Teva, and OraSure, is very exciting,” he said.

Richard is a welcome addition to the Kymanox team, CEO and Founder Stephen M. Perry remarked. “With Richard now directing our established Process Operations and Validation groups, this new leadership position lays a solid foundation for future, sustainable growth,” he said. “This helps make the Kymanox team even more capable to address challenges with bringing modern medicines to patients in need across the globe.”


22FEB17: Kymanox welcomes Ash Patel

Kymanox is pleased to announce the on-boarding of Ash Patel for the position of Senior Director of Client Services. He will be leading the Business Development team to expand the Kymanox Brand and help new clients.